Carregant...
Cerebrospinal fluid GAP-43 in early multiple sclerosis
BACKGROUND/OBJECTIVE: Novel biomarkers identifying and predicting disease activity in multiple sclerosis (MS) would be valuable for primary diagnosis and as outcome measures for monitoring therapeutic effects in clinical trials. Axonal loss is present from the earliest stages of MS and correlates wi...
Guardat en:
| Publicat a: | Mult Scler J Exp Transl Clin |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
SAGE Publications
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6081760/ https://ncbi.nlm.nih.gov/pubmed/30094057 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2055217318792931 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|